| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |